Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03303534 · ClinicalTrials.gov registry record · NA
Short-Term Endogenous Hydrogen Sulfide Upregulation
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03303534: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT03303534 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03303534, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This research study will compare the impact of dietary restriction pre-operatively before carotid endarterectomy compared to the standard nutrition that a patient typically eats. The investigators want to find out how patients comply and generally how well patients do with this type of dietary restriction before their surgery since animal studies suggest that short - term dietary restriction may be beneficial before surgery.
Primary Outcome
will measure subject compliance via direct dietary intake data by way of written food diary and biologic markers (serum markers including plasma free amino acids and insulin-like growth factor).
Interventions
- DIETARY_SUPPLEMENT ScandiShake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2018-06-01 |
| Phase | NA |
What the finished NCT03303534 record still lists
NCT03303534 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ScandiShake is the first listed.
NCT03303534 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03303534 about?
NCT03303534 is a clinical study titled "Short-Term Endogenous Hydrogen Sulfide Upregulation". This research study will compare the impact of dietary restriction pre-operatively before carotid endarterectomy compared to the standard nutrition that a patient typically eats. The investigators want to find out how patients comply and generally how well patients do with this type of dietary restr...
What is the current status of trial NCT03303534?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-09-14. Estimated completion is 2018-06-01.
What interventions are being tested in trial NCT03303534?
The interventions under investigation include: ScandiShake (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03303534?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03303534's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI